SUNSHINE PHARMA (06887) intends to repurchase company shares.
Dongyang Guangyao (06887) announces that the company intends to repurchase its own shares on the open market. The management of the company is optimistic about the group...
SUNSHINE PHARMA (06887) announced that the company intends to repurchase its own shares on the open market. The management team is confident in the future prospects of the group, and the proposed buyback reflects the board and management team's confidence in the long-term business prospects and development of the company. The board believes that the proposed buyback is in the best interests of the company and its shareholders overall.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
